The state of Kansas is willing to spend billions on the Chiefs, the “it” team of the recent past. But what happens if the ...

Arrowhead Pharmaceuticals (ARWR) is back in focus after fresh regulatory approvals for REDEMPLO in China and Canada, along ...

Tom Brady didn’t just call Saturday’s Seahawks – 49ers atmosphere loud; he put Seattle’s home field in the same conversation ...

As of Wednesday, January 07, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 7.85%, which has investors questioning if this is right time to buy.

Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

Arrowhead Pharmaceuticals, a leader in RNAi therapeutics, reported a significant insider sale amid a year of exceptional stock gains.

The use of poison on arrows marked a revolution in human hunting technology—new evidence suggests it happened tens of ...

Shares of Arrowhead Pharmaceuticals rose after the company reported positive interim data from two Phase 1/2 trials for obesity treatments. The stock was up 17%, at $74.61, late Tuesday morning and ...

Arrowhead Pharmaceuticals recently announced that Health Canada issued a Notice of Compliance for REDEMPLO (plozasiran) as an adjunct treatment to lower triglycerides in adults with familial ...

On December 17, 2025, TheFly reported that Piper Sandler maintained its Overweight rating for Arrowhead Pharmaceuticals, Inc.

In terms of liquidity and interest, the mean open interest for Arrowhead Pharma options trades today is 878.14 with a total volume of 5,476.00.

The Arrowhead Union School District is considering eliminating open enrollment after two failed referendums. At least one couple is hoping that doesn't happen.